EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice

Gracián Camps, Sheila Maestro, Laura Torella, Diego Herrero, Carla Usai, Martin Bilbao-Arribas iD, Ana Aldaz, Cristina Olagüe, Africa Vales, Lester Suárez-Amarán, Rafael Aldabe, Gloria Gonzalez-Aseguinolaza iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1011749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Gracián Camps und 11 weiteren Autor:innen. Beteiligte Einrichtung: DNA & RNA Medicine Division, CIMA, University of Navarra, Instituto de Investigación Sanitaria de Navarra, IdisNA, Pamplona, Spain. Hauptthemen laut MEDLINE: Hepatocytes, Receptor-Interacting Protein Serine-Threonine Kinases, Cytokines, Hepatitis Delta Virus. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Proyectos I+D de Generación de Conocimiento, European Union – NextGenerationEU, Recovery, Transformation and Resilience Plan, Agencia Estatal de Investigación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis delta virus (HDV) infection represents the most severe form of human viral hepatitis; however, the mechanisms underlying its pathology remain incompletely understood. We recently developed an HDV mouse model by injecting adeno-associated viral vectors (AAV) containing replication-competent HBV and HDV genomes. This model replicates many features of human infection, including liver injury. Notably, the extent of liver damage can be diminished with anti-TNF-α treatment. Here, we found that TNF-α is mainly produced by macrophages. Downstream of the TNF-α receptor (TNFR), the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) serves as a cell fate regulator, playing roles in both cell survival and death pathways. In this study, we explored the function of RIPK1 and other host factors in HDV-induced cell death. We determined that the scaffolding function of RIPK1, and not its kinase activity, offers partial protection against HDV-induced apoptosis. A reduction in RIPK1 expression in hepatocytes through CRISPR-Cas9-mediated gene editing significantly intensifies HDV-induced damage. Contrary to our expectations, the protective effect of RIPK1 was not linked to TNF-α or macrophage activation, as their absence did not alter the extent of damage. Intriguingly, in the absence of RIPK1, macrophages confer a protective role. However, in animals unresponsive to type-I IFNs, RIPK1 downregulation did not exacerbate the damage, suggesting RIPK1’s role in shielding hepatocytes from type-I IFN-induced cell death. Interestingly, while the damage extent is similar between IFNα/βR KO and wild type mice in terms of transaminase elevation, their cell death mechanisms differ. In conclusion, our findings reveal that HDV-induced type-I IFN production is central to inducing hepatocyte death, and RIPK1’s scaffolding function offers protective benefits. Thus, type-I IFN together with TNF-α, contribute to HDV-induced liver damage. These insights may guide the development of novel therapeutic strategies to mitigate HDV-induced liver damage and halt disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesReceptor-Interacting Protein Serine-Threonine KinasesCytokinesHepatitis Delta VirusAnimalsMiceHepatitis DCell DeathMice, Inbred C57BLApoptosisMice, KnockoutHumansTumor Necrosis Factor-alphaDisease Models, Animal

Substanzen

Ripk1 protein, mouseReceptor-Interacting Protein Serine-Threonine KinasesCytokinesTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • DNA & RNA Medicine Division, CIMA, University of Navarra, Instituto de Investigación Sanitaria de Navarra, IdisNA, Pamplona, Spain.

ORCID-Profile: Martin Bilbao-Arribas, Gloria Gonzalez-Aseguinolaza

Förderung

  • Proyectos I+D de Generación de Conocimiento
  • European Union – NextGenerationEU, Recovery, Transformation and Resilience Plan
  • Agencia Estatal de Investigación
  • Instituto de Salud Carlos III
  • FIMA

Zitieren

APA

Camps, G., Maestro, S., Torella, L., Herrero, D., Usai, C., Bilbao-Arribas, M., Aldaz, A., Olagüe, C., Vales, A., Suárez-Amarán, L., Aldabe, R., & Gonzalez-Aseguinolaza, G. (2024). Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011749

Vancouver

Camps G, Maestro S, Torella L, Herrero D, Usai C, Bilbao-Arribas M, et al. Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1011749

BibTeX
@article{Camps2024,
  author = {Camps, Gracián and Maestro, Sheila and Torella, Laura and Herrero, Diego and Usai, Carla and Bilbao-Arribas, Martin and Aldaz, Ana and Olagüe, Cristina and Vales, Africa and Suárez-Amarán, Lester and Aldabe, Rafael and Gonzalez-Aseguinolaza, Gloria},
  title = {Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1011749}
}
Kostenlos starten →